Arne Dietrich

Arne Dietrich

Auto-generated profile, based on publicly available information

Arne Dietrich

American University of Beirut

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SDSimon N. Dankel
Simon N. Dankel
EGElise Grytten
Elise Grytten
JBJan-Inge Bjune
Jan-Inge Bjune
HNHans Jørgen Nielsen
Hans Jørgen Nielsen
ADArne Dietrich
Arne Dietrich
GMGunnar Mellgren
Gunnar Mellgren
Fibrillar collagen COL6α3 in adipose tissue has been associated with obesity, inflammation, insulin resistance and cancer. We here aimed to identify novel transcriptional regulators of COL6A3 expression. Based on a transcriptome dataset of adipose tissue, we identified strong correlations for 56 genes with COL6A3 mRNA, including targets of TGF-β/SMAD signaling. Among the identified candidates, the homeobox transcription factor PRRX1 showed a particularly striking co-expression with COL6A3, validated across several different cohorts, including patients with extreme obesity, insulin sensitive and resistant obesity (subcutaneous and omental), after profound fat loss (subcutaneous), and lean controls (subcutaneous). In human and mouse adipose cells, PRRX1 knockdown reduced COL6A3 mRNA and PRRX1 overexpression transactivated a reporter construct with the endogenous human COL6A3 promoter. Stable PRRX1 overexpression in 3T3-L1 cells induced Col6a3 mRNA threefold specifically after adipogenic induction, whereas TGF-β1 treatment upregulated Col6a3 mRNA also in the preadipocyte state. Interestingly, pro-inflammatory stimulus (i.e., TNF-α treatment) decreased PRRX1-mediated Col6a3 transactivation and mRNA expression, supporting a role for this mechanism in the regulation of adipose tissue inflammation. In conclusion, we identified the homeobox factor PRRX1 as a novel transcriptional regulator associated with COL6A3 expression, providing new insight into the regulatory mechanisms of altered adipose tissue function in obesity and insulin resistance.

1 September 2020 in International Journal of Obesity
Verified
Journal Article
Open access
PDF file
AMArij Mulhem
Arij Mulhem
YMYusef Moulla
Yusef Moulla
NKNora Kloting
Nora Kloting
TEThomas Ebert
Thomas Ebert
ATAnke Tönjes
Anke Tönjes
MBMatthias Blüher
Matthias Blüher
Background/Objectives: People with metabolically healthy obesity (MHO) may still have an increased risk for cardiovascular mortality compared to metabolically healthy lean (MHL) individuals. However, the mechanisms linking obesity to cardiovascular diseases are not entirely understood. We therefore tested the hypothesis that circulating cell adhesion molecules (CAMs) are higher in MHO compared to MHL individuals. Subjects/Methods: Serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular adhesion molecule-1 (sVCAM-1), E-selectin and P-selectin were measured in age- and sex-matched groups of MHL (n = 32), MHO categorized into BMI-matched insulin sensitive (IS, n = 32) or insulin resistant (IR) obesity (n = 32) and people with metabolically unhealthy obesity (MUO, n = 32). Results: Indeed, individuals with MHO have significantly higher sICAM-1, E-selectin, and P-selectin serum concentrations compared to MHL people. However, these CAMs are still significantly lower in IS compared to IR MHO. There was no difference between the groups in sVCAM-1 serum concentrations. Compared to all other groups, circulating adhesion molecules were significantly higher in individuals with MUO. Conclusions: These findings suggest that obesity-related increased cardiovascular risk is reflected and may be mediated by significantly higher CAMs. The mechanisms causing elevated adhesion molecules even in the absence of overt cardio-metabolic risk factors and whether circulating CAMs could predict cardiovascular events need to be explored.

1 September 2019 in Contemporary Clinical Trials Communications
Verified
Journal Article
Open access
Philipp SimonPhilipp Simon
Philipp Simon
DPDavid Petroff
David Petroff
CDChristoph Dorn
Christoph Dorn
LEL. Ehmann
L. Ehmann
CKCharlotte Kloft
Charlotte Kloft
HWHermann Wrigge
Hermann Wrigge
Pharmacokinetic (PK) and pharmacodynamic (PD) data on perioperative antibiotic prophylaxis or antibiotic therapy are rare in patients suffering from morbid obesity. Furthermore, dosing regimens should be based on PK/PD models that ensure effective antibiotic exposure not in plasma, but primarily at the site of infection, mostly in the interstitial fluid (ISF). The aim of this trial is to investigate whether current dosing regimens of various antibiotics lead to effective concentrations in the ISF of morbidly obese patients. We designed a prospective, parallel group, open-labeled, controlled single center trial to investigate the plasma and tissue pharmacokinetics of the antibiotics linezolid, meropenem, tigecycline, piperacillin/tazobactam, fosfomcyine, cefazolin, metronidazole and as secondary aim the analgesics metamizole and acetaminophen. Inclusion criteria comprise body mass index ≥35 kg/m2 for obese or between 18.5 and 30 kg/m2 for non-obese patients scheduled for elective abdominal surgery. For PK analysis, blood and microdialysate samples of subcutaneous tissue were collected 0-8 h after study drug administration. The primary endpoint is to investigate a possible dependency of the area-under-the-curve (AUC0-8) in the interstitial fluid on body weight and obesity with population based pharmacokinetic analysis. Inadequate dosing regimes of antibiotics may be a relevant factor for morbidity and mortality of patients, as well as for the development of bacterial antibiotic resistance. The measurement of plasma and tissue concentrations will provide information necessary for PK/PD-modelling. These data about antibiotic PK/PDcharacteristics in soft tissue and their dependence on weight should help to develop weight-dependent models for calculation of patient's individual doses of different antibiotics. EU clinical trials register (EudraCT-No. 2012-004383-22) and German Clinical trials Register (DRKS00004776).

29 June 2016 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
IWI. V. Wagner
I. V. Wagner
GFG. Flehmig
G. Flehmig
KSK. Scheuermann
K. Scheuermann
DLD. Löffler
D. Löffler
AKAntje Körner
Antje Körner
KSK. Svechnikov
K. Svechnikov
Insulin-like peptide 5 (INSL5) is a gut hormone produced by L-cells in the colorectal epithelium and may play a role in the regulation of metabolic processes. The biological role of INSL5 is poorly investigated and nothing is known about the role of this hormone in obese and lean humans. Two cohorts were analyzed in the study. In the first cohort (n=76) the relationship between serum levels of INSL5 and different metabolic and hormonal parameters in obese and lean men and women were investigated. In the second cohort 14 male subjects underwent bariatric surgery. Circulating levels of INSL5 were then measured before and after interventions. We report for the first time that circulating INSL5 interacts with multiple metabolic and hormonal variables in lean and obese men and women and is affected by bariatric surgery. Serum levels of INSL5 negatively correlated with testosterone and blood lipids but positively with cortisol in obese men. In contrast to males, obese women had a strong negative correlation of plasma levels of INSL5 with C-reactive protein (CRP). We observed that adipose tissue loss after bariatric surgery significantly reduced serum levels of INSL5 in obese men with and without Type 2 Diabetes Mellitus (T2DM) that was associated with the restoration of circulating levels of testosterone. All together, our data demonstrated that INSL5 may interact with some metabolic parameters in obese humans and this process is dependent of gender and obesity state.

13 August 2023 in Future in Educational Research
Verified
Journal Article
Open access
ADArne Dietrich
Arne Dietrich
SZSandra Zakka
Sandra Zakka
The concept of multiple intelligences has taken hold in education. The idea that there are different types of intelligence for different domains helps inform educational approaches to learning and development. Evidence in creativity research, particularly from neuroscience, is accumulating that there are also different types of creativity. This, however, has not been the predominant way neuroscience has approached creativity. Consequently, the idea of different types of creativity has also not yet taken hold in education. Despite psychology regarding creativity as being made up of many complex, multifaceted, and varied cognitive and emotional processes deployed across many different domains, we still think of, and test, creativity as if it were a single, separate, cohesive, and discrete thing. Having perseverated on experimental paradigms that are theoretically and conceptually incoherent, this paper explains why empirical neuroscience research has failed to identify and distinguish different types of creativity. This is particularly important because neuroscience can take a lead in establishing the idea of multiple creativity types. The paper then outlines the negative implications for education if creativity is continuously being treated as a single faculty or monolithic entity. Finally, the paper introduces a division of creativity into three types that could result in a more individual approach to teaching and promoting creativity in classrooms.

1 September 1997 in Psychobiology
Verified
Journal Article
Open access
PDF file
ADArne Dietrich
Arne Dietrich
DFDavid L. Frederick
David L. Frederick
JAJoseph D. Allen
Joseph D. Allen
Two peak procedure experiments studied the effects of different prefrontal cortex lesions on temporal discrimination in rats. In Experiment 1, lesions were made to either the medial frontal cortex (including medial precentral, anterior cingulate, prelimbic, and infralimbic cortex) or the ventral frontal cortex (including orbital area and agranular insular area) to determine the contribution of each to time estimation. In Experiment 2, lesions were made to the entire prefrontal cortex (including the medial frontal cortex and the ventral frontal cortex). In both experiments, rats were trained with a 40-sec peak interval and tested for 14 postoperative sessions. In Experiment 1, peak time and response distributions showed timing behavior unaffected by either lesion. In Experiment 2, ablations of the prefrontal cortex (PFC) produced a leftward shift in the temporal discrimination functions, indicating that these animals expected the time of reinforcement to be early. Also, these discrimination functions were substantially flattened, which was interpreted as a general decline in timing ability. These results are inconsistent with those of earlier studies. It is concluded that PFC functions as a unit with respect to timing behavior.